Ochi Testuro, Katayama Yuta, Okatani Takeshi, Imanaka Ryota, Kyo Kohei, Itagaki Mitsuhiro, Katsutani Shinya, Iwato Koji, Asaoku Hideki
Department of Hematology and Rheumatology, Tohoku University Hospital, 1-1, Seiryomachi, Aoba-ku Sendai-shi, Miyagi 980-0872, Japan.
Department of Hematology, Hiroshima Red Cross & Atomic-bomb Survivors' Hospital, 1-9-6, Sendamachi, Naka-ku Hiroshima-shi, Hiroshima 730-0052, Japan.
Med Mycol Case Rep. 2017 Jul 4;18:1-4. doi: 10.1016/j.mmcr.2017.07.002. eCollection 2017 Dec.
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy. As zygomycosis could not be cured by liposomal amphotericin B and micafungin, left lower lobectomy was performed. As AML relapsed 7 months after onset, she received haploidentical stem cell transplantation under administration of liposomal amphotericin B. Despite experiencing severe acute graft-versus-host disease, she remains alive with no relapse of either zygomycosis or AML.
一名54岁的急性髓系白血病(AML)女性患者通过诱导化疗实现了完全缓解,但在巩固治疗后发生了接合菌病。由于脂质体两性霉素B和米卡芬净无法治愈接合菌病,遂进行了左下叶切除术。由于AML在发病7个月后复发,她在接受脂质体两性霉素B治疗的同时接受了单倍体相合干细胞移植。尽管经历了严重的急性移植物抗宿主病,但她仍然存活,接合菌病和AML均未复发。